(ZGN) Ermenegildo Zegna - Overview
Sector: Consumer CyclicalIndustry: Apparel Manufacturing | Exchange NYSE (USA) | Currency USD | Market Cap: 2.744m | Total Return 42.2% in 12m
Stock: Menswear, Womenswear, Footwear, Leather Goods, Accessories
Total Rating 64
Risk 77
Buy Signal -1.37
| Risk 5d forecast | |
|---|---|
| Volatility | 43.7% |
| Relative Tail Risk | -7.60% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.91 |
| Alpha | 24.50 |
| Character TTM | |
|---|---|
| Beta | 1.251 |
| Beta Downside | 1.947 |
| Drawdowns 3y | |
|---|---|
| Max DD | 60.99% |
| CAGR/Max DD | -0.15 |
EPS (Earnings per Share)
Revenue
Description: ZGN Ermenegildo Zegna March 04, 2026
Ermenegildo Zegna N.V. (ZGN) is an Italian luxury fashion house. It designs, manufactures, and distributes a wide range of luxury goods globally.
The companys product portfolio includes menswear, womens wear, childrens clothing, footwear, and leather goods. It also offers accessories such as eyewear, jewelry, and fragrances. The luxury goods sector is characterized by high-margin products and strong brand loyalty.
ZGN markets its products under brands including ZEGNA, Thom Browne, and TOM FORD FASHION. Distribution occurs through both retail stores and online channels. The business model emphasizes direct-to-consumer sales, common in luxury retail to maintain brand control and customer experience.
For further analysis of ZGNs financial performance and market position, consider exploring its detailed reports on ValueRay.
Headlines to watch out for
- Luxury consumer spending trends impact sales
- Brand perception and marketing effectiveness drive demand
- Raw material costs influence profit margins
- Global economic conditions affect luxury goods market
- Supply chain disruptions risk production and delivery
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 175.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 4.95 > 1.0 |
| NWC/Revenue: 11.40% < 20% (prev 8.09%; Δ 3.31% < -1%) |
| CFO/TA 0.22 > 3% & CFO 619.7m > Net Income 175.3m |
| Net Debt (757.3m) to EBITDA (586.0m): 1.29 < 3 |
| Current Ratio: 1.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (266.3m) vs 12m ago 3.04% < -2% |
| Gross Margin: 64.12% > 18% (prev 0.64%; Δ 6.35k% > 0.5%) |
| Asset Turnover: 137.7% > 50% (prev 123.1%; Δ 14.59% > 0%) |
| Interest Coverage Ratio: 5.64 > 6 (EBITDA TTM 586.0m / Interest Expense TTM 61.4m) |
Altman Z'' 3.02
| A: 0.16 (Total Current Assets 1.19b - Total Current Liabilities 750.1m) / Total Assets 2.83b |
| B: 0.26 (Retained Earnings 739.3m / Total Assets 2.83b) |
| C: 0.12 (EBIT TTM 346.3m / Avg Total Assets 2.80b) |
| D: 0.31 (Book Value of Equity 535.4m / Total Liabilities 1.73b) |
| Altman-Z'' Score: 3.02 = A |
Beneish M -3.14
| DSRI: 0.96 (Receivables 260.4m/240.5m, Revenue 3.86b/3.41b) |
| GMI: 1.00 (GM 64.12% / 64.32%) |
| AQI: 0.97 (AQ_t 0.28 / AQ_t-1 0.28) |
| SGI: 1.13 (Revenue 3.86b / 3.41b) |
| TATA: -0.16 (NI 175.3m - CFO 619.7m) / TA 2.83b) |
| Beneish M-Score: -3.14 (Cap -4..+1) = AA |
What is the price of ZGN shares?
As of March 27, 2026, the stock is trading at USD 9.91 with a total of 628,661 shares traded.
Over the past week, the price has changed by +7.14%, over one month by -14.57%, over three months by -5.35% and over the past year by +42.16%.
Over the past week, the price has changed by +7.14%, over one month by -14.57%, over three months by -5.35% and over the past year by +42.16%.
Is ZGN a buy, sell or hold?
Ermenegildo Zegna has received a consensus analysts rating of 3.43.
Therefor, it is recommend to hold ZGN.
- StrongBuy: 2
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the ZGN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 11.9 | 19.7% |
| Analysts Target Price | 11.9 | 19.7% |
ZGN Fundamental Data Overview March 27, 2026
Market Cap EUR = 2.37b (2.74b USD * 0.8629 USD.EUR)
P/E Trailing = 23.25
P/E Forward = 22.7273
P/S = 1.4315
P/B = 2.2932
Revenue TTM = 3.86b EUR
EBIT TTM = 346.3m EUR
EBITDA TTM = 586.0m EUR
Long Term Debt = 162.1m EUR (from longTermDebt, last fiscal year)
Short Term Debt = 224.9m EUR (from shortTermDebt, last quarter)
Debt = 977.4m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 757.3m EUR (from netDebt column, last quarter)
Enterprise Value = 3.05b EUR (2.37b + Debt 977.4m - CCE 295.7m)
Interest Coverage Ratio = 5.64 (Ebit TTM 346.3m / Interest Expense TTM 61.4m)
EV/FCF = 7.03x (Enterprise Value 3.05b / FCF TTM 433.8m)
FCF Yield = 14.22% (FCF TTM 433.8m / Enterprise Value 3.05b)
FCF Margin = 11.25% (FCF TTM 433.8m / Revenue TTM 3.86b)
Net Margin = 4.54% (Net Income TTM 175.3m / Revenue TTM 3.86b)
Gross Margin = 64.12% ((Revenue TTM 3.86b - Cost of Revenue TTM 1.38b) / Revenue TTM)
Gross Margin QoQ = 56.01% (prev 67.48%)
Tobins Q-Ratio = 1.08 (Enterprise Value 3.05b / Total Assets 2.83b)
Interest Expense / Debt = 2.55% (Interest Expense 24.9m / Debt 977.4m)
Taxrate = 14.49% (10.4m / 71.5m)
NOPAT = 296.1m (EBIT 346.3m * (1 - 14.49%))
Current Ratio = 1.59 (Total Current Assets 1.19b / Total Current Liabilities 750.1m)
Debt / Equity = 0.95 (Debt 977.4m / totalStockholderEquity, last quarter 1.03b)
Debt / EBITDA = 1.29 (Net Debt 757.3m / EBITDA 586.0m)
Debt / FCF = 1.75 (Net Debt 757.3m / FCF TTM 433.8m)
Total Stockholder Equity = 921.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.26% (Net Income 175.3m / Total Assets 2.83b)
RoE = 19.02% (Net Income TTM 175.3m / Total Stockholder Equity 921.2m)
RoCE = 31.97% (EBIT 346.3m / Capital Employed (Equity 921.2m + L.T.Debt 162.1m))
RoIC = 23.61% (NOPAT 296.1m / Invested Capital 1.25b)
WACC = 7.98% (E(2.37b)/V(3.35b) * Re(10.38%) + D(977.4m)/V(3.35b) * Rd(2.55%) * (1-Tc(0.14)))
Discount Rate = 10.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.14%
[DCF] Terminal Value 79.22% ; FCFF base≈374.9m ; Y1≈393.5m ; Y5≈460.0m
[DCF] Fair Price = 27.65 (EV 8.17b - Net Debt 757.3m = Equity 7.42b / Shares 268.2m; r=7.98% [WACC]; 5y FCF grow 5.37% → 3.0% )
EPS Correlation: 10.56 | EPS CAGR: 3.22% | SUE: 0.0 | # QB: 0
Revenue Correlation: 69.06 | Revenue CAGR: 13.60% | SUE: -0.15 | # QB: 0
EPS current Year (2026-12-31): EPS=0.39 | Chg7d=-0.006 | Chg30d=-0.011 | Revisions Net=-1 | Growth EPS=-12.5% | Growth Revenue=+4.4%
EPS next Year (2027-12-31): EPS=0.52 | Chg7d=-0.001 | Chg30d=-0.012 | Revisions Net=+0 | Growth EPS=+31.0% | Growth Revenue=+7.9%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 6.1% (Discount Rate 10.4% - Earnings Yield 4.3%)
[Growth] Growth Spread = +1.8% (Analyst 7.9% - Implied 6.1%)
P/E Trailing = 23.25
P/E Forward = 22.7273
P/S = 1.4315
P/B = 2.2932
Revenue TTM = 3.86b EUR
EBIT TTM = 346.3m EUR
EBITDA TTM = 586.0m EUR
Long Term Debt = 162.1m EUR (from longTermDebt, last fiscal year)
Short Term Debt = 224.9m EUR (from shortTermDebt, last quarter)
Debt = 977.4m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 757.3m EUR (from netDebt column, last quarter)
Enterprise Value = 3.05b EUR (2.37b + Debt 977.4m - CCE 295.7m)
Interest Coverage Ratio = 5.64 (Ebit TTM 346.3m / Interest Expense TTM 61.4m)
EV/FCF = 7.03x (Enterprise Value 3.05b / FCF TTM 433.8m)
FCF Yield = 14.22% (FCF TTM 433.8m / Enterprise Value 3.05b)
FCF Margin = 11.25% (FCF TTM 433.8m / Revenue TTM 3.86b)
Net Margin = 4.54% (Net Income TTM 175.3m / Revenue TTM 3.86b)
Gross Margin = 64.12% ((Revenue TTM 3.86b - Cost of Revenue TTM 1.38b) / Revenue TTM)
Gross Margin QoQ = 56.01% (prev 67.48%)
Tobins Q-Ratio = 1.08 (Enterprise Value 3.05b / Total Assets 2.83b)
Interest Expense / Debt = 2.55% (Interest Expense 24.9m / Debt 977.4m)
Taxrate = 14.49% (10.4m / 71.5m)
NOPAT = 296.1m (EBIT 346.3m * (1 - 14.49%))
Current Ratio = 1.59 (Total Current Assets 1.19b / Total Current Liabilities 750.1m)
Debt / Equity = 0.95 (Debt 977.4m / totalStockholderEquity, last quarter 1.03b)
Debt / EBITDA = 1.29 (Net Debt 757.3m / EBITDA 586.0m)
Debt / FCF = 1.75 (Net Debt 757.3m / FCF TTM 433.8m)
Total Stockholder Equity = 921.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.26% (Net Income 175.3m / Total Assets 2.83b)
RoE = 19.02% (Net Income TTM 175.3m / Total Stockholder Equity 921.2m)
RoCE = 31.97% (EBIT 346.3m / Capital Employed (Equity 921.2m + L.T.Debt 162.1m))
RoIC = 23.61% (NOPAT 296.1m / Invested Capital 1.25b)
WACC = 7.98% (E(2.37b)/V(3.35b) * Re(10.38%) + D(977.4m)/V(3.35b) * Rd(2.55%) * (1-Tc(0.14)))
Discount Rate = 10.38% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.14%
[DCF] Terminal Value 79.22% ; FCFF base≈374.9m ; Y1≈393.5m ; Y5≈460.0m
[DCF] Fair Price = 27.65 (EV 8.17b - Net Debt 757.3m = Equity 7.42b / Shares 268.2m; r=7.98% [WACC]; 5y FCF grow 5.37% → 3.0% )
EPS Correlation: 10.56 | EPS CAGR: 3.22% | SUE: 0.0 | # QB: 0
Revenue Correlation: 69.06 | Revenue CAGR: 13.60% | SUE: -0.15 | # QB: 0
EPS current Year (2026-12-31): EPS=0.39 | Chg7d=-0.006 | Chg30d=-0.011 | Revisions Net=-1 | Growth EPS=-12.5% | Growth Revenue=+4.4%
EPS next Year (2027-12-31): EPS=0.52 | Chg7d=-0.001 | Chg30d=-0.012 | Revisions Net=+0 | Growth EPS=+31.0% | Growth Revenue=+7.9%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 6.1% (Discount Rate 10.4% - Earnings Yield 4.3%)
[Growth] Growth Spread = +1.8% (Analyst 7.9% - Implied 6.1%)